StockData
TG Therapeutics, Inc. logo

TG Therapeutics, Inc. (TGTX) stock

TGTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 9/3010% above fair value
$66.12+3.41 (+5.44%)

Close on Nov 18, 2026Market cap $10.12BP/E 24.1Yield –

TG Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

TG Therapeutics's market cap was $10.07B on Nov 11, 2026, against $5.16B a year earlier. Over the last 5 years it ranged from $614.30M to $10.07B, with a median of $3.63B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$10.07B+117.6%
2025Dec 31, 2025$4.63B-1.3%
2024Dec 31, 2024$4.69B+81.3%
2023Dec 29, 2023$2.59B+50.4%
2022Dec 30, 2022$1.72B-36.7%
2021Dec 31, 2021$2.72B-59.5%
2020Dec 31, 2020$6.71B+525.3%
2019Dec 31, 2019$1.07B+215.4%
2018Dec 31, 2018$340.02M-41.3%
2017Dec 29, 2017$579.35M+127.7%
2016Dec 30, 2016$254.47M-59.4%
2015Dec 31, 2015$626.53M-4.6%
2014Dec 31, 2014$656.41M+403.9%
2013Dec 31, 2013$130.26M+98.2%
2012Dec 31, 2012$65.72M+44313.3%
2011Dec 30, 2011$147.97K–

More TG Therapeutics figures

See a number that looks wrong?